| In EUR m | Q1 2024 | Q1 2023 |
| Revenue | 453.4 | 409.9 |
| EBITDA (adjusted) | 108.4 | 97.2 |
| Exceptional items | -4.7 | -2.8 |
| EBITDA | 103.8 | 94.4 |
| Amortization, depreciation and impairment | -76.9 | -76.0 |
| thereof attributable to purchase price allocations and impairment losses | -3.2 | -4.9 |
| EBIT | 26.9 | 18.3 |
| Net finance income/costs | -18.3 | -13.6 |
| EBT | 8.6 | 4.7 |
| Taxes | -2.6 | -1.3 |
| Consolidated profit or loss for the period | 6.0 | 3.4 |
| Adjusted consolidated profit or loss for the period | 12.5 | 8.9 |
| Free cash flow (before M&A transactions) | 24.6 | 21.2 |
| Free cash flow (before M&A transactions)(Adjusted) | -24.4 | -14.5 |
| Net debt (Mar. 31/Dec. 31) | 782.8 | 770.0 |
